Gabapentin Capsule
Product Images NDC 0904-7613

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 0904-7613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg100 Unit-dose Label (Gabapentin Cap 100 100c)

100 mg100 Unit-dose Label (Gabapentin Cap 100 100c)
These are Gabapentin capsules from Major Pharmaceuticals, each containing 100mg of Gabapentin USP. The medication guide should be given to each patient. Each box contains 100 capsules (10x10). It is essential to refer to the package insert for complete prescribing details. The product should be stored at 20° to 25°C (68° to 77°F). The capsules are meant for unit dose administration. The manufacturer is Alkem Laboratories Ltd. from Mumbai, India. This information is for prescription use only.*
FDA Label Image

300 mg100 Unit-dose Label (Gabapentin Cap 300 100c)

300 mg100 Unit-dose Label (Gabapentin Cap 300 100c)
This is a description of Gabapentin Capsules, USP, manufactured by Alkem Laboratories Ltd. and distributed by MAJOR® PHARMACEUTICALS in the USA. The capsules contain 300 mg Gabapentin USP each and are packaged in 100 capsules (10x10). It is a prescription-only medication with a dosage and use instructions provided in the package insert. The medication guide should be dispensed to each patient. The storage temperature recommended is 20° to 25°C (68° to 77°F).*
FDA Label Image

400 mg100 Unit-dose Label (Gabapentin Cap 400 100c)

400 mg100 Unit-dose Label (Gabapentin Cap 400 100c)
This is a description for Gabapentin capsules with a strength of 400mg. The medication guide should be distributed to each patient. The product is manufactured by Alkem Laboratories Ltd in India and distributed by Major Pharmaceuticals in the USA. It is recommended to store the capsules at temperatures between 20° to 25°C. Each capsule contains Gabapentin USP 400mg. The prescription is for 100 capsules in a package size of 10x10. For complete prescribing information, refer to the package insert.*
FDA Label Image

Gabapentin-equation (Gabapentin Equation)

Gabapentin-equation (Gabapentin Equation)
This text provides information on age, weight, serum creatinine level, and a correction factor for female patients for Cl levels. The age is recorded as 140 years, weight in kilograms, serum creatinine in mg/dl, and a correction factor is mentioned for Cl levels in female patients.*
FDA Label Image

Structure (Gabapentin Fig 5)

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
This text provides information about a study on pain management, specifically focusing on the mean pain score. The study involved a 4-week dose titration period followed by a 4-week fixed dose period comparing the effects of a placebo versus Gabapentin at a dosage of 3600 mg/day. The baseline pain score seems to be the starting point for the evaluation.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Gabapentin-fig2 (Gabapentin Fig2)
This text appears to be describing a study on pain management involving different dosages of Gabapentin and a placebo. The study includes a titration period and a fixed dose period. The mean pain scores at baseline and after weeks are likely to be analyzed to measure the effectiveness of different doses of Gabapentin.*
FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

Gabapentin-fig3 (Gabapentin Fig3)
This text provides statistical data on the proportion of responders in controlled PHN (postherpetic neuralgia) studies, specifically in comparison to different drug dosages. The chart shows the percentage of patients who experienced at least a 50% reduction in pain score at the study endpoint. The studies involved different dosages of the medication GBP (Gabapentin) such as GBP 3600, GBP 2400, GEBP 1800, and a placebo (PBO). The data suggests that higher dosages of GBP may lead to a higher proportion of responders in treating PHN. The significance level is also mentioned as p<0.001.*
FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.